Intravenous Ig consists of pooled human serum IgG and is widely used as an antiinflammatory agent. The fraction of IgG that is α2,6-sialylated exhibits anti-inflammatory activity and sialylation is proposed to enable binding to the cell surface lectin, dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin (DC-SIGN) (1). In a recent article in PNAS, Sondermann et al. propose a mechanism to explain the putative sialic acid-dependent binding of IgG Fc to DC-SIGN, as well as to the IgE receptor, CD23 (2). The core of their hypothesis is that sialylation of IgG Fc leads to a conformational change, which triggers DC-SIGN binding. To directly assess this hypothesis, we have generated α2,6-sialylated IgG1 Fc (sFc) that we both chemically verified by HPLC analysis (Fig. 1A) and structurally characterized by X-ray crystallographic analysis to a resolution of 2.3 Å (Fig. 1 B and C, and Table 1) .
We observe no conformational changes to the Fc upon sialylation. In particular, we find no evidence of a "closed" state resembling the structure of IgE in complex with CD23 that could account for the reported interaction with DC-SIGN or CD23 (2). Instead, the tertiary and quaternary structure of sFc is strikingly similar to that of a previously reported IgG structure bearing nonsialylated-but still galactosylated-complextype glycans (e.g., rmsd of 0.8 Å over 405 equivalent Cα positions with PDB ID 1H3Y) (Fig. 1B) . In addition, we are currently in the process of refining the structure of an alternative low-resolution sFc crystal formed in low salt, pH 7.5, which also appears to exhibit a typical, "native-like" structure. Although large alterations in Fc conformations are conceivable, our data suggest that lattice or pH effects do not preclude their observation by X-ray crystallography.
Our crystallographic analysis also shows that Fc sialylation does not perturb the classic protein-carbohydrate interactions observed of asialylated IgG Fc (Fig. 1C) . We note that these observations are consistent with solution-state NMR measurements (3). We observe extensive electron density corresponding to 20 monosaccharide residues (Fig. 1C ). There are two sialic acid attachment sites per biantennary N-linked glycan on the "3-arm" and "6-arm" (Fig. 1C) . There is observable electron density for sialic acid on the 6-arm and, in contrast with the proposed model by Sondermann et al. (2), this glycan moiety projects in a solvent-exposed manner away from the protein surface. Similarly, the 3-arm is not, as proposed, tightly immobilized to the protein surface but is instead entirely solvent exposed.
We note that the experimental support for the proposed conformational changes includes circular dichroism, which gives exquisitely sensitive readouts to changes in local but not tertiary or quaternary structure. In addition, the melting temperature shift observed by Sondermann et al. (2) is well within the range of other Fc glycoforms, whereas deglycosylation leads to a more significant change in stability (4).
In light of these results, the mechanism by which sialylated IgG Fc mediates antiinflammatory activity must remain an open question. Indeed, although DC-SIGN may well function in the immunological signaling pathway, there is still some uncertainty as to whether there is a direct interaction between sialylated IgG Fc and DC-SIGN (5). . For crystallographic analysis, sFc (6.5 mg/mL) was crystallized at 25°C in 4.0 M NaCl, 0.1 M citrate pH 4.0 using the sitting-drop vapor-diffusion method using 100 nL protein plus 100 nL precipitant equilibrated against 95-μL reservoirs. Crystals were flash-frozen by immersion in a cryoprotectant containing the mother liquor diluted in 5 M NaCl and then rapidly transferred to a gaseous nitrogen stream. X-ray diffraction data were recorded at the Beamline I04 at Diamond Light Source, Oxfordshire, England. Data were processed and scaled using XIA2 and the structure was solved using Phaser with native Fc (PDB ID code 3AVE) as a search model. Model building was performed with Coot and iteratively refined in the CCP4 supported program REFMAC5. Coordinates and structure factors of sFc have been deposited in the Protein Data Bank (PDB ID code 4BYH). 
